Evidence map›Paper›PMID 38243058›Full record

ArticleNPJ precision oncology2024

Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer.

Yongjun Liu, Yuqing Xu, Xiaoxing Li, Mengke Chen, Xueqin Wang, Ning Zhang, Heping Zhang, Zhengjun Zhang

Open access · goldAbstract read
In one paragraph

Article in NPJ precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Yongjun LiuDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, USA.
Yuqing XuDepartment of Statistics, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0002-8753-9345
Xiaoxing LiState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. Lixiaox23@mail.sysu.edu.cn.
Mengke ChenState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Xueqin WangDepartment of Statistics and Finance, University of Science and Technology of China, Hefei, China.ORCID http://orcid.org/0000-0001-5205-9950
Ning ZhangDepartment of Gastroenterology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Heping ZhangYale School of Public Health, Yale University, New Haven, CT, USA.
Zhengjun ZhangDepartment of Statistics, University of Wisconsin-Madison, Madison, WI, USA. zjz@stat.wisc.edu.ORCID http://orcid.org/0000-0003-2615-1539
Sun Yat-sen University · CNUniversity of Wisconsin–Madison · USUniversity of Science and Technology of China · CNUniversity of Washington Medical Center · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Analysis of Big Data Squared in Biomedical StudiesR01MH116527 · NIMH · YALE UNIVERSITY · PI ZHANG, HEPING · 2018 to 2022
$2.3M
Analysis of Genomic and Complex DataR01HG010171 · NHGRI · YALE UNIVERSITY · PI ZHANG, HEPING · 2019 to 2022
$1.4M
NCATS NIH HHS UL1 TR001863NHGRI NIH HHS R01 HG010171NIMH NIH HHS R01 MH116527
6 · The paper itself

Abstract

The goal of this study was to use a new interpretable machine-learning framework based on max-logistic competing risk factor models to identify a parsimonious set of differentially expressed genes (DEGs) that play a pivotal role in the development of colorectal cancer (CRC). Transcriptome data from nine public datasets were analyzed, and a new Chinese cohort was collected to validate the findings. The study discovered a set of four critical DEGs - CXCL8, PSMC2, APP, and SLC20A1 - that exhibit the highest accuracy in detecting CRC in diverse populations and ethnicities. Notably, PSMC2 and CXCL8 appear to play a central role in CRC, and CXCL8 alone could potentially serve as an early-stage marker for CRC. This work represents a pioneering effort in applying the max-logistic competing risk factor model to identify critical genes for human malignancies, and the interpretability and reproducibility of the results across diverse populations suggests that the four DEGs identified can provide a comprehensive description of the transcriptomic features of CRC. The practical implications of this research include the potential for personalized risk assessment and precision diagnosis and tailored treatment plans for patients.

Identifiers

PMID38243058
PMCPMC10799029
OpenAlexW4391042170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.